BACKGROUND: Minimally invasive techniques are progressively challenging traditional approaches in cardiothoracic surgery. Minimally invasive aortic valve replacement (AVR) has become a routine procedure at our institution. METHODS: We retrospectively analyzed all patients undergoing minimally invasive isolated AVR between January 2003 and March 2014, at our institution. Mean follow-up was 4.7±4.3 years (range: 0-18 years) and was 99.8% complete. RESULTS: There were 1,714 patients who received an isolated minimally invasive AVR. The mean (± SD) patient age was 65±12.8 years, ejection fraction 60%±12% and log EuroSCORE 5.3%±5.1%. Mean cross-clamp time was 58±18 minutes and mean cardiopulmonary bypass (CPB) time was 82.9±26.7 minutes. Thirty-day survival was 97.8%±0.4%, and 69.4%±1.7% at 10-years. The multivariate analysis revealed age at surgery [P=0.016; odds ratio (OR), 1.1], length of surgery time (P=0.002; OR, 1.01), female gender (P=0.023; OR, 3.54), preoperative myocardial infarction (MI) (P=0.006; OR, 7.87), preoperative stroke (P=0.001; OR, 13.76) and preoperative liver failure (P=0.015; OR, 10.28) as independent risk factors for mortality. Cox-regression analysis revealed the following predictors for long term mortality: age over 75 years (P<0.001; OR, 3.5), preoperative dialysis (P<0.01; OR, 2.14), ejection fraction less than 30% (P=0.003; OR, 3.28) and urgent or emergency operation (P<0.001; OR, 2.3). CONCLUSIONS: Minimally invasive AVR can be performed safely and effectively with very few perioperative complications. The early and long-term outcomes in these patients are acceptable.
BACKGROUND: Minimally invasive techniques are progressively challenging traditional approaches in cardiothoracic surgery. Minimally invasive aortic valve replacement (AVR) has become a routine procedure at our institution. METHODS: We retrospectively analyzed all patients undergoing minimally invasive isolated AVR between January 2003 and March 2014, at our institution. Mean follow-up was 4.7±4.3 years (range: 0-18 years) and was 99.8% complete. RESULTS: There were 1,714 patients who received an isolated minimally invasive AVR. The mean (± SD) patient age was 65±12.8 years, ejection fraction 60%±12% and log EuroSCORE 5.3%±5.1%. Mean cross-clamp time was 58±18 minutes and mean cardiopulmonary bypass (CPB) time was 82.9±26.7 minutes. Thirty-day survival was 97.8%±0.4%, and 69.4%±1.7% at 10-years. The multivariate analysis revealed age at surgery [P=0.016; odds ratio (OR), 1.1], length of surgery time (P=0.002; OR, 1.01), female gender (P=0.023; OR, 3.54), preoperative myocardial infarction (MI) (P=0.006; OR, 7.87), preoperative stroke (P=0.001; OR, 13.76) and preoperative liver failure (P=0.015; OR, 10.28) as independent risk factors for mortality. Cox-regression analysis revealed the following predictors for long term mortality: age over 75 years (P<0.001; OR, 3.5), preoperative dialysis (P<0.01; OR, 2.14), ejection fraction less than 30% (P=0.003; OR, 3.28) and urgent or emergency operation (P<0.001; OR, 2.3). CONCLUSIONS: Minimally invasive AVR can be performed safely and effectively with very few perioperative complications. The early and long-term outcomes in these patients are acceptable.
Authors: Tomislav Mihaljevic; Lawrence H Cohn; Daniel Unic; Sary F Aranki; Gregory S Couper; John G Byrne Journal: Ann Surg Date: 2004-09 Impact factor: 12.969
Authors: Nicolas Doll; Michael A Borger; Joerg Hain; Jan Bucerius; Thomas Walther; Jan F Gummert; Friedrich W Mohr Journal: Ann Thorac Surg Date: 2002-10 Impact factor: 4.330
Authors: Denis R Merk; Sven Lehmann; David M Holzhey; Pascal Dohmen; Pascal Candolfi; Martin Misfeld; Friedrich W Mohr; Michael A Borger Journal: Eur J Cardiothorac Surg Date: 2014-03-05 Impact factor: 4.191
Authors: Alfred A Kocher; Günther Laufer; Axel Haverich; Malakh Shrestha; Thomas Walther; Martin Misfeld; Joerg Kempfert; Linda Gillam; Christoph Schmitz; Thorsten C Wahlers; Jens Wippermann; Friedrich W Mohr; Matthias Roth; Adalbert Skwara; Parwis Rahmanian; Dominik Wiedemann; Michael A Borger Journal: J Thorac Cardiovasc Surg Date: 2012-10-08 Impact factor: 5.209
Authors: Sven Lehmann; Thomas Walther; Sergey Leontjev; Jörg Kempfert; Ardawan Rastan; Jens Garbade; Michael A Borger; Volkmar Falk; Friedrich W Mohr Journal: J Heart Valve Dis Date: 2007-11
Authors: Helen C Hancock; Rebecca H Maier; Adetayo Kasim; James Mason; Gavin Murphy; Andrew Goodwin; W Andrew Owens; Enoch Akowuah Journal: BMJ Open Date: 2021-01-29 Impact factor: 2.692